Global Multiplex Assay Market, Product( Instruments, Consumables, [Reagents And Kits, Microplates And Micropipettes, And Others], Software), Technology (Multiplex RT-PCR, Flow Cytometry, Fluorescence, Luminescence, And Others), Type ( Protein [planar and bead-based] Nucleic Acid, And Cell) ,Application (Research & Development, [Drug Discovery & Development And Biomarker Research & Application] Diagnosis, [Infectious Diseases, Autoimmune Diseases, Cancer, Cardiovascular Diseases, Neuro-Endocrine Diseases, And Others] And Others) ,End-user( Academic And Research Centers, Biotechnology And Biopharmaceutical Companies, Diagnostic Centers, Hospitals, And Others)and opportunities and forecast 2020-2027
Multiplex Assay Market Overview
The multiplex assay is a process in which many analytes such as proteins, biomolecules, chemokines, cytolines, and others are outlined by noticing and measuring them. This assay is used to increase different targets in a polymerase chain reaction (PCR) and gather the bulk of information from small amounts of proteins or other analytes in less time as compared to conventional methods such as ELISA. In addition, multiplex assays are extensively used for RNA detection, linkage analysis, pathogen identification, mutation analysis, and others.
The Multiplex Assay Market is observing noteworthy growth, due to increasing R & D activities for the pharmaceutical sector for the treatment of many diseases. The Multiplex Assay is used for quick and easier analysis of diseases and they are automated, hence fueling the multiplex assay market growth. few other key aspects positively affecting the growth of the multiplex assay market are the rising incidence of infectious diseases and cancer that can be easily observed at earlier stages, government and private funding for research and innovation activities. Besides, strategic acquisitions of companies to enhance the reach of the multiplex assay kits further boost the growth of the market.
Progress in the highly dense nanoarray technology has made the drug screening process fast and time-effective. Rising awareness of people for various diseases, cancer and Alzheimer’s disease, etc. created a requirement for cost-effective and time-saving measurement of multiple analytes in a single sample. These are some reasons facilitating the global multiplex assay market development.
On the other hand, factors such as lack of skilled laborers and high capital investment are hampering the market growth.
Multiplex Assay Market Segment Overview
The flow cytometry segment has hold a remarkable share in the market in 2017. This is due to the ease of performing multiplex assays through technology, which offers the flexibility of running a large number of samples simultaneously with accuracy. The consumables segment is anticipated to show good growth during the forecast period owing to the huge increase in research and development by major market players. Expansion of the protein segment can be done due to an increase in analyzing protein samples exactly and simultaneously for dynamic and static, predictive, and biological research.
The increasing focus on the establishment of biotechnology companies in emerging economies. Furthermore, an increase in the number of biotechnology companies, globally, mainly in Europe and Asia, is expected to boost the growth in the market
Because of the Covid-19 pandemic, top market players speed up their operations for testing and tracking the infection of COVID-19. This has given a chance for accelerating growth for companies operating in the Multiplex Assays market
Multiplex Assay Regional Overview
North America is expected to hold its dominance in terms of market share over the forecast period. This is due to the bigger adoption of the multiplex assay. The major reasons contributing to growth in market development are the increase in technological advancement, the presence of advanced healthcare infrastructures as well as increased occurrence of various chronic disorders, etc. Asia Pacific region is expected to show remarkable growth in coming years owing to increased adoption of advanced technology, rising demand for safe and effective treatment options, and the launching of new products.
Multiplex Assay Market Competitor overview
Multiplex Assay market, which is highly competitive, involves various market players. A few of major market players are Luminex Corporation, Thermo Fisher Scientific, Inc., Seegene, Inc., Meso Scale Diagnostics, LLC., Abcam plc, Bio-Rad Laboratories, Inc., QIAGEN N.V., Merck KGaA, Quansys Biosciences, and Illumina, Inc.
In April 2020, Bio-Rad Laboratories Inc., one of the major players in the global multiplex assay market, declared that it has received the Emergency Use Authorization by the U.S FDA for its Droplet Digital PCR (ddPCR) SARS-CoV-2 Test Kit that runs on Bio-Rad's QX200 and QXDx ddPCR systems. Owing to the good sensitivity of this test it is well for screening upper respiratory track samples in patients in the early stage of infection, or patients recovering from the infection.
Also, in the same month, Bio-Rad Laboratories, Inc., announced the launch of ‘Serology Assay,’ a blood-based immunoassay kit, formulated to identify antibodies to the virus associated with the COVID-19 pandemic, the SARS-CoV-2. Of the 700 samples detected by this test, 99% success results have been achieved.
Furthermore, in March 2020, Thermo Fisher Scientific, announced the launch of its five new Thermo Scientific SureTect PCR Assay test kits, along with updated software to test food and related samples. These test kits are used for examining the existence of Cronobacter species, Listeria species, Listeria monocytogenes, Salmonella Enteritidis, and Salmonella Typhimurium, in food products and consumables.
Multiplex Assay Market, Key Players
Luminex Corporation
Thermo Fisher Scientific, Inc.
Seegene, Inc.,
Meso Scale Diagnostics, LLC.
Abcam plc
Bio-Rad Laboratories, Inc.
QIAGEN N.V.
Merck KGaA
Quansys Biosciences
Illumina, Inc.
Becton
Dickinson and Company
Abcam PLC, Seegene Inc.
Multiplex Assay Market Segmentation
Multiplex Assay Market, By Type
Protein
Planar
Bead-Based
Nucleic Acid
Cell
Multiplex Assay Market, By Product
Instruments
Consumables
Reagents and Kits
Microplates and Micropipettes
Others
Software
Multiplex Assay Market, By Technology
Multiplex RT-PCR
Flow Cytometry
Fluorescence
Luminescence
Others
Multiplex Assay Market, By Application
Research & Development
Drug Discovery & Development
Biomarker Research & Application
Diagnosis
Infectious Diseases
Autoimmune Diseases
Cancer
Cardiovascular Diseases
Neuro-Endocrine Diseases
Others
Others
Multiplex Assay Market, By End-user
Academic and Research Centers
Biotechnology and Biopharmaceutical Companies
Diagnostic Centers
Hospitals
Others
Multiplex Assay market, By Region:
North America
US
Canada
Europe
UK
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
South America
Brazil
Argentina
Rest of South America
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Key Emerging Trends – For Major Countries
4.2. Latest Technological Advancement
4.3. Regulatory Landscape
4.4. Industry SWOT Analysis
4.5. Porters Five Forces Analysis
5. Global Multiplex Assay Market Analysis (USD Billion), Insights and Forecast, 2020-2027
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Type
5.2.1. Protein
5.2.1.1. Planar
5.2.1.2. Bead-Based
5.2.2. Nucleic Acid
5.2.3. Cell
5.3. Market Analysis, Insights and Forecast – By Product
5.3.1. Instruments
5.3.2. Consumables
5.3.2.1. Reagents and Kits
5.3.2.2. Microplates and Micropipettes
5.3.2.3. Others
5.3.3. Software
5.4. Market Analysis, Insights and Forecast – By Technology
5.4.1. Multiplex RT-PCR
5.4.2. Flow Cytometry
5.4.3. Fluorescence
5.4.4. Luminescence
5.4.5. Others
5.5. Market Analysis, Insights and Forecast – By Application
5.5.1. Research & Development
5.5.1.1. Drug Discovery & Development
5.5.1.2. Biomarker Research & Application
5.5.2. Diagnosis
5.5.2.1. Infectious Diseases
5.5.2.2. Autoimmune Diseases
5.5.2.3. Cancer
5.5.2.4. Cardiovascular Diseases
5.5.2.5. Neuro-Endocrine Diseases
5.5.2.6. Others
5.5.3. Others
5.6. Market Analysis, Insights and Forecast – By End-user
5.6.1. Academic and Research Centers
5.6.2. Biotechnology and Biopharmaceutical Companies
5.6.3. Diagnostic Centers
5.6.4. Hospitals
5.6.5. Others
5.7. Market Analysis, Insights and Forecast – By Region
5.7.1. North America
5.7.2. Latin America
5.7.3. Europe
5.7.4. Asia Pacific
5.7.5. Middle East and Africa
6. North America Multiplex Assay Market Analysis (USD Billion), Insights and Forecast, 2020-2027
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Type
6.2.1. Protein
6.2.1.1. Planar
6.2.1.2. Bead-Based
6.2.2. Nucleic Acid
6.2.3. Cell
6.3. Market Analysis, Insights and Forecast – By Product
6.3.1. Instruments
6.3.2. Consumables
6.3.2.1. Reagents and Kits
6.3.2.2. Microplates and Micropipettes
6.3.2.3. Others
6.3.3. Software
6.4. Market Analysis, Insights and Forecast – By Technology
6.4.1. Multiplex RT-PCR
6.4.2. Flow Cytometry
6.4.3. Fluorescence
6.4.4. Luminescence
6.4.5. Others
6.5. Market Analysis, Insights and Forecast – By Application
6.5.1. Research & Development
6.5.1.1. Drug Discovery & Development
6.5.1.2. Biomarker Research & Application
6.5.2. Diagnosis
6.5.2.1. Infectious Diseases
6.5.2.2. Autoimmune Diseases
6.5.2.3. Cancer
6.5.2.4. Cardiovascular Diseases
6.5.2.5. Neuro-Endocrine Diseases
6.5.2.6. Others
6.5.3. Others
6.6. Market Analysis, Insights and Forecast – By End-user
6.6.1. Academic and Research Centers
6.6.2. Biotechnology and Biopharmaceutical Companies
6.6.3. Diagnostic Centers
6.6.4. Hospitals
6.6.5. Others
6.7. Market Analysis, Insights and Forecast – By Country
6.7.1. U.S.
6.7.2. Canada
7. Latin America Multiplex Assay Market Analysis (USD Billion), Insights and Forecast, 2020-2027
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Type
7.2.1. Protein
7.2.1.1. Planar
7.2.1.2. Bead-Based
7.2.2. Nucleic Acid
7.2.3. Cell
7.3. Market Analysis, Insights and Forecast – By Product
7.3.1. Instruments
7.3.2. Consumables
7.3.2.1. Reagents and Kits
7.3.2.2. Microplates and Micropipettes
7.3.2.3. Others
7.3.3. Software
7.4. Market Analysis, Insights and Forecast – By Technology
7.4.1. Multiplex RT-PCR
7.4.2. Flow Cytometry
7.4.3. Fluorescence
7.4.4. Luminescence
7.4.5. Others
7.5. Market Analysis, Insights and Forecast – By Application
7.5.1. Research & Development
7.5.1.1. Drug Discovery & Development
7.5.1.2. Biomarker Research & Application
7.5.2. Diagnosis
7.5.2.1. Infectious Diseases
7.5.2.2. Autoimmune Diseases
7.5.2.3. Cancer
7.5.2.4. Cardiovascular Diseases
7.5.2.5. Neuro-Endocrine Diseases
7.5.2.6. Others
7.5.3. Others
7.6. Market Analysis, Insights and Forecast – By End-user
7.6.1. Academic and Research Centers
7.6.2. Biotechnology and Biopharmaceutical Companies
7.6.3. Diagnostic Centers
7.6.4. Hospitals
7.6.5. Others
7.7. Insights and Forecast – By Country
7.7.1. Brazil
7.7.2. Mexico
7.7.3. Rest of Latin America
8. Europe Multiplex Assay Market Analysis (USD Billion), Insights and Forecast, 2020-2027
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast – By Type
8.2.1. Protein
8.2.1.1. Planar
8.2.1.2. Bead-Based
8.2.2. Nucleic Acid
8.2.3. Cell
8.3. Market Analysis, Insights and Forecast – By Product
8.3.1. Instruments
8.3.2. Consumables
8.3.2.1. Reagents and Kits
8.3.2.2. Microplates and Micropipettes
8.3.2.3. Others
8.3.3. Software
8.4. Market Analysis, Insights and Forecast – By Technology
8.4.1. Multiplex RT-PCR
8.4.2. Flow Cytometry
8.4.3. Fluorescence
8.4.4. Luminescence
8.4.5. Others
8.5. Market Analysis, Insights and Forecast – By Application
8.5.1. Research & Development
8.5.1.1. Drug Discovery & Development
8.5.1.2. Biomarker Research & Application
8.5.2. Diagnosis
8.5.2.1. Infectious Diseases
8.5.2.2. Autoimmune Diseases
8.5.2.3. Cancer
8.5.2.4. Cardiovascular Diseases
8.5.2.5. Neuro-Endocrine Diseases
8.5.2.6. Others
8.5.3. Others
8.6. Market Analysis, Insights and Forecast – By End-user
8.6.1. Academic and Research Centers
8.6.2. Biotechnology and Biopharmaceutical Companies
8.6.3. Diagnostic Centers
8.6.4. Hospitals
8.6.5. Others
8.7. Market Analysis, Insights and Forecast – By Country
8.7.1. UK
8.7.2. Germany
8.7.3. France
8.7.4. Italy
8.7.5. Spain
8.7.6. Russia
8.7.7. Rest of Europe
9. Asia Pacific Multiplex Assay Market Analysis (USD Billion), Insights and Forecast, 2020-2027
9.1. Key Findings / Summary
9.2. Market Analysis, Insights and Forecast – By Type
9.2.1. Protein
9.2.1.1. Planar
9.2.1.2. Bead-Based
9.2.2. Nucleic Acid
9.2.3. Cell
9.3. Market Analysis, Insights and Forecast – By Product
9.3.1. Instruments
9.3.2. Consumables
9.3.2.1. Reagents and Kits
9.3.2.2. Microplates and Micropipettes
9.3.2.3. Others
9.3.3. Software
9.4. Market Analysis, Insights and Forecast – By Technology
9.4.1. Multiplex RT-PCR
9.4.2. Flow Cytometry
9.4.3. Fluorescence
9.4.4. Luminescence
9.4.5. Others
9.5. Market Analysis, Insights and Forecast – By Application
9.5.1. Research & Development
9.5.1.1. Drug Discovery & Development
9.5.1.2. Biomarker Research & Application
9.5.2. Diagnosis
9.5.2.1. Infectious Diseases
9.5.2.2. Autoimmune Diseases
9.5.2.3. Cancer
9.5.2.4. Cardiovascular Diseases
9.5.2.5. Neuro-Endocrine Diseases
9.5.2.6. Others
9.5.3. Others
9.6. Market Analysis, Insights and Forecast – By End-user
9.6.1. Academic and Research Centers
9.6.2. Biotechnology and Biopharmaceutical Companies
9.6.3. Diagnostic Centers
9.6.4. Hospitals
9.6.5. Others
9.7. Market Analysis, Insights and Forecast – By Country
9.7.1. China
9.7.2. India
9.7.3. Japan
9.7.4. Australia
9.7.5. South East Asia
9.7.6. Rest of Asia Pacific
10. Middle East & Africa Multiplex Assay Market Analysis (USD Billion), Insights and Forecast, 2020-2027
10.1. Key Findings / Summary
10.2. Market Analysis, Insights and Forecast – By Type
10.2.1. Protein
10.2.1.1. Planar
10.2.1.2. Bead-Based
10.2.2. Nucleic Acid
10.2.3. Cell
10.3. Market Analysis, Insights and Forecast – By Product
10.3.1. Instruments
10.3.2. Consumables
10.3.2.1. Reagents and Kits
10.3.2.2. Microplates and Micropipettes
10.3.2.3. Others
10.3.3. Software
10.4. Market Analysis, Insights and Forecast – By Technology
10.4.1. Multiplex RT-PCR
10.4.2. Flow Cytometry
10.4.3. Fluorescence
10.4.4. Luminescence
10.4.5. Others
10.5. Market Analysis, Insights and Forecast – By Application
10.5.1. Research & Development
10.5.1.1. Drug Discovery & Development
10.5.1.2. Biomarker Research & Application
10.5.2. Diagnosis
10.5.2.1. Infectious Diseases
10.5.2.2. Autoimmune Diseases
10.5.2.3. Cancer
10.5.2.4. Cardiovascular Diseases
10.5.2.5. Neuro-Endocrine Diseases
10.5.2.6. Others
10.5.3. Others
10.6. Market Analysis, Insights and Forecast – By End-user
10.6.1. Academic and Research Centers
10.6.2. Biotechnology and Biopharmaceutical Companies
10.6.3. Diagnostic Centers
10.6.4. Hospitals
10.6.5. Others
10.7. Market Analysis, Insights and Forecast – By Country
10.7.1. GCC
10.7.2. South Africa
10.7.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Company Market Share Analysis, 2018
11.2. Key Industry Developments
11.3. Company Profile
11.4. Luminex Corporation
11.4.1. Business Overview
11.4.2. Segment 1 & Service Offering
11.4.3. Overall Revenue
11.4.4. Geographic Presence
11.4.5. Recent Development
*Similar details will be provided for the following companies
11.5. Thermo Fisher Scientific, Inc.
11.6. Seegene, Inc.,
11.7. Meso Scale Diagnostics, LLC.
11.8. Abcam plc
11.9. Bio-Rad Laboratories, Inc.
11.10. QIAGEN N.V.
11.11. Merck KGaA
11.12. Quansys Biosciences
11.13. Illumina, Inc.
11.14. Becton
11.15. Dickinson and Company
11.16. Abcam PLC, Seegene Inc.
11.17. Creative Group, Inc.
11.18. the Interpublic Group of Companies, Inc.
List of Figures
Figure 1: Global Multiplex Assay Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
Figure 2: Global Multiplex Assay Market Value Share (%), By Segment 1, 2019 & 2027
Figure 3: Global Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 4: Global Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 5: Global Multiplex Assay Market Value Share (%), By Segment 2, 2019 & 2027
Figure 6: Global Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 7: Global Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 8: Global Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 9: Global Multiplex Assay Market Forecast (USD Billion), by Others, 2016-2027
Figure 10: Global Multiplex Assay Market Value Share (%), By Segment 3, 2019 & 2027
Figure 11: Global Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 12: Global Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 13: Global Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 14: Global Multiplex Assay Market Forecast (USD Billion), by Others, 2016-2027
Figure 15: Global Multiplex Assay Market Value (USD Billion), by Region, 2019 & 2027
Figure 16: North America Multiplex Assay Market Value Share (%), By Segment 1, 2019 & 2027
Figure 17: North America Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 18: North America Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 19: North America Multiplex Assay Market Value Share (%), By Segment 2, 2019 & 2027
Figure 20: North America Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 21: North America Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 22: North America Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 23: North America Multiplex Assay Market Forecast (USD Billion), by Others, 2016-2027
Figure 24: North America Multiplex Assay Market Value Share (%), By Segment 3, 2019 & 2027
Figure 25: North America Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 26: North America Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 27: North America Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 28: North America Multiplex Assay Market Forecast (USD Billion), by Others, 2016-2027
Figure 29: North America Multiplex Assay Market Forecast (USD Billion), by U.S., 2016-2027
Figure 30: North America Multiplex Assay Market Forecast (USD Billion), by Canada, 2016-2027
Figure 31: Latin America Multiplex Assay Market Value Share (%), By Segment 1, 2019 & 2027
Figure 32: Latin America Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 33: Latin America Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 34: Latin America Multiplex Assay Market Value Share (%), By Segment 2, 2019 & 2027
Figure 35: Latin America Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 36: Latin America Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 37: Latin America Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 38: Latin America Multiplex Assay Market Forecast (USD Billion), by Others, 2016-2027
Figure 39: Latin America Multiplex Assay Market Value Share (%), By Segment 3, 2019 & 2027
Figure 40: Latin America Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 41: Latin America Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 42: Latin America Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 43: Latin America Multiplex Assay Market Forecast (USD Billion), by Others, 2016-2027
Figure 44: Latin America Multiplex Assay Market Forecast (USD Billion), by Brazil, 2016-2027
Figure 45: Latin America Multiplex Assay Market Forecast (USD Billion), by Mexico, 2016-2027
Figure 46: Latin America Multiplex Assay Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
Figure 47: Europe Multiplex Assay Market Value Share (%), By Segment 1, 2019 & 2027
Figure 48: Europe Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 49: Europe Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 50: Europe Multiplex Assay Market Value Share (%), By Segment 2, 2019 & 2027
Figure 51: Europe Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 52: Europe Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 53: Europe Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 54: Europe Multiplex Assay Market Forecast (USD Billion), by Others, 2016-2027
Figure 55: Europe Multiplex Assay Market Value Share (%), By Segment 3, 2019 & 2027
Figure 56: Europe Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 57: Europe Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 58: Europe Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 59: Europe Multiplex Assay Market Forecast (USD Billion), by Others, 2016-2027
Figure 60: Europe Multiplex Assay Market Forecast (USD Billion), by U.K., 2016-2027
Figure 61: Europe Multiplex Assay Market Forecast (USD Billion), by Germany, 2016-2027
Figure 62: Europe Multiplex Assay Market Forecast (USD Billion), by France, 2016-2027
Figure 63: Europe Multiplex Assay Market Forecast (USD Billion), by Italy, 2016-2027
Figure 64: Europe Multiplex Assay Market Forecast (USD Billion), by Spain, 2016-2027
Figure 65: Europe Multiplex Assay Market Forecast (USD Billion), by Russia, 2016-2027
Figure 66: Europe Multiplex Assay Market Forecast (USD Billion), by Rest of Europe, 2016-2027
Figure 67: Asia Pacific Multiplex Assay Market Value Share (%), By Segment 1, 2019 & 2027
Figure 68: Asia Pacific Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 69: Asia Pacific Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 70: Asia Pacific Multiplex Assay Market Value Share (%), By Segment 2, 2019 & 2027
Figure 71: Asia Pacific Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 72: Asia Pacific Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 73: Asia Pacific Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 74: Asia Pacific Multiplex Assay Market Forecast (USD Billion), by Others, 2016-2027
Figure 75: Asia Pacific Multiplex Assay Market Value Share (%), By Segment 3, 2019 & 2027
Figure 76: Asia Pacific Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 77: Asia Pacific Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 78: Asia Pacific Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 79: Asia Pacific Multiplex Assay Market Forecast (USD Billion), by Others, 2016-2027
Figure 80: Asia Pacific Multiplex Assay Market Forecast (USD Billion), by China, 2016-2027
Figure 81: Asia Pacific Multiplex Assay Market Forecast (USD Billion), by India, 2016-2027
Figure 82: Asia Pacific Multiplex Assay Market Forecast (USD Billion), by Japan, 2016-2027
Figure 83: Asia Pacific Multiplex Assay Market Forecast (USD Billion), by Australia, 2016-2027
Figure 84: Asia Pacific Multiplex Assay Market Forecast (USD Billion), by Southeast Asia, 2016-2027
Figure 85: Asia Pacific Multiplex Assay Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
Figure 86: Middle East & Africa Multiplex Assay Market Value Share (%), By Segment 1, 2019 & 2027
Figure 87: Middle East & Africa Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 88: Middle East & Africa Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 89: Middle East & Africa Multiplex Assay Market Value Share (%), By Segment 2, 2019 & 2027
Figure 90: Middle East & Africa Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 91: Middle East & Africa Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 92: Middle East & Africa Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 93: Middle East & Africa Multiplex Assay Market Forecast (USD Billion), by Others, 2016-2027
Figure 94: Middle East & Africa Multiplex Assay Market Value Share (%), By Segment 3, 2019 & 2027
Figure 95: Middle East & Africa Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 96: Middle East & Africa Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 97: Middle East & Africa Multiplex Assay Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 98: Middle East & Africa Multiplex Assay Market Forecast (USD Billion), by Others, 2016-2027
Figure 99: Middle East & Africa Multiplex Assay Market Forecast (USD Billion), by GCC, 2016-2027
Figure 100: Middle East & Africa Multiplex Assay Market Forecast (USD Billion), by South Africa, 2016-2027
Figure 101: Middle East & Africa Multiplex Assay Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027
List of Tables
Table 1: Global Multiplex Assay Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 2: Global Multiplex Assay Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 3: Global Multiplex Assay Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 4: Global Multiplex Assay Market Revenue (USD Billion) Forecast, by Region, 2016-2027
Table 5: North America Multiplex Assay Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 6: North America Multiplex Assay Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 7: North America Multiplex Assay Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 8: North America Multiplex Assay Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 9: Europe Multiplex Assay Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 10: Europe Multiplex Assay Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 11: Europe Multiplex Assay Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 12: Europe Multiplex Assay Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 13: Latin America Multiplex Assay Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 14: Latin America Multiplex Assay Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 15: Latin America Multiplex Assay Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 16: Latin America Multiplex Assay Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 17: Asia Pacific Multiplex Assay Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 18: Asia Pacific Multiplex Assay Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 19: Asia Pacific Multiplex Assay Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 20: Asia Pacific Multiplex Assay Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 21: Middle East & Africa Multiplex Assay Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 22: Middle East & Africa Multiplex Assay Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 23: Middle East & Africa Multiplex Assay Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 24: Middle East & Africa Multiplex Assay Market Revenue (USD Billion) Forecast, by Country, 2016-2027
